A Trial of Inebilizumab in Participants With Autoimmune Hepatitis
Clinical trial NCT07598825 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07598825
- Sponsor
- Amgen
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-07
- Primary completion
- 2031-07-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.